Prospect Capital Corporation invests $18 million in TCSPV Holdings IV, enhancing addiction treatment services at The Ridge facility.
Quiver AI Summary
Prospect Capital Corporation and an affiliate have provided about $18 million in a first lien senior secured term loan, a revolving credit facility, and an equity investment to TCSPV Holdings IV, LLC, known as The Ridge, in partnership with Thesis Capital Partners. The Ridge is a physician-led addiction treatment facility that combines evidence-based clinical treatments with holistic therapies in a luxury residential setting, catering primarily to professionals in the high-end substance abuse market. Prospect's Managing Director, David Moszer, expressed enthusiasm for supporting The Ridge's growth, while Thesis Capital Partners' Founder, Ian J.H. Reynolds, praised the organization's unique model focused on privacy and clinical excellence.
Potential Positives
- Prospect Capital has made a significant investment of approximately $18 million in TCSPV Holdings IV, LLC, indicating confidence in the company's growth potential in the addiction treatment sector.
- The partnership with Thesis Capital Partners adds credibility and strategic support for The Ridge, enhancing Prospect's position in a niche, upscale market focused on substance abuse treatment.
- The Ridge's focus on providing personalized and evidence-based care in a luxurious setting aligns with current trends in high-quality healthcare services, suggesting a strong market demand and potential profitability.
Potential Negatives
- The investment in The Ridge, a company focused on addiction treatment, may expose Prospect to reputational risks associated with the sensitive nature of the healthcare industry and potential regulatory scrutiny.
- The press release heavily emphasizes forward-looking statements, which may indicate uncertainty regarding the future performance and stability of the investment, potentially signaling risk to investors.
- The collaboration with Thesis Capital Partners might suggest that Prospect is relying on external partners for growth, raising questions about its own operational capabilities and strategic direction.
FAQ
What is the recent investment by Prospect Capital Corporation?
Prospect Capital Corporation has provided approximately $18 million in loans and equity investment to The Ridge, a physician-led addiction treatment facility.
What services does The Ridge offer?
The Ridge offers a range of addiction treatment services, including detoxification and outpatient care, combining clinical and holistic therapies.
Who partnered with Prospect in this investment?
Thesis Capital Partners collaborated with Prospect in providing financial support to The Ridge.
What is the focus of The Ridge's treatment model?
The Ridge focuses on providing high-end substance abuse treatment, emphasizing privacy, professionalism, and transformative care.
What is the investment objective of Prospect Capital Corporation?
Prospect's investment objective is to generate current income and long-term capital appreciation through lending to middle market companies.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$PSEC Insider Trading Activity
$PSEC insiders have traded $PSEC stock on the open market 15 times in the past 6 months. Of those trades, 15 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $PSEC stock by insiders over the last 6 months:
- JOHN F BARRY (CHIEF EXECUTIVE OFFICER) has made 12 purchases buying 3,782,300 shares for an estimated $15,211,487 and 0 sales.
- WILLIAM GREMP has made 3 purchases buying 20,000 shares for an estimated $85,799 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$PSEC Hedge Fund Activity
We have seen 117 institutional investors add shares of $PSEC stock to their portfolio, and 129 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- KINGSTONE CAPITAL PARTNERS TEXAS, LLC added 23,798,618 shares (+inf%) to their portfolio in Q2 2025, for an estimated $75,679,605
- MARSHALL WACE, LLP added 3,907,025 shares (+inf%) to their portfolio in Q2 2025, for an estimated $12,424,339
- BALYASNY ASSET MANAGEMENT L.P. added 2,405,299 shares (+73.9%) to their portfolio in Q2 2025, for an estimated $7,648,850
- THOMAS J. HERZFELD ADVISORS, INC. removed 2,315,582 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $7,363,550
- TUDOR INVESTMENT CORP ET AL added 2,171,772 shares (+1444.0%) to their portfolio in Q2 2025, for an estimated $6,906,234
- TWO SIGMA INVESTMENTS, LP removed 1,409,309 shares (-40.7%) from their portfolio in Q2 2025, for an estimated $4,481,602
- MILLENNIUM MANAGEMENT LLC added 1,346,273 shares (+1127.5%) to their portfolio in Q2 2025, for an estimated $4,281,148
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$PSEC Analyst Ratings
Wall Street analysts have issued reports on $PSEC in the last several months. We have seen 0 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Underweight" rating on 08/28/2025
To track analyst ratings and price targets for $PSEC, check out Quiver Quantitative's $PSEC forecast page.
Full Release
NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Prospect Capital Corporation (“Prospect”) (NASDAQ: PSEC) and an affiliate have provided a first lien senior secured term loan, a first lien senior secured revolving credit facility, and an equity investment to TCSPV Holdings IV, LLC (“The Ridge” or “Company”), aggregating approximately $18 million, in collaboration with Thesis Capital Partners.
The Ridge is a physician-led addiction treatment facility that delivers personalized care in a luxurious residential setting. The Company offers a wide array of services, from detoxification to outpatient care, integrating evidence-based clinical treatments with holistic therapies.
“Prospect is pleased to provide growth capital to The Ridge to work in collaboration with Thesis Capital Partners and The Ridge management team,” said David Moszer, Managing Director at Prospect. “The Ridge is a differentiated treatment facility focused on professionals in the high-end substance abuse market. We look forward to supporting the Company’s continued growth.”
“We deeply appreciate Prospect's responsiveness in providing value-added capital to The Ridge,” said Ian J.H. Reynolds, Founder & Managing Partner of Thesis Capital Partners. “The Ridge has built an exceptional team with a clinically unique model focused on privacy, professionalism, and real outcomes. We are proud to support the organization’s mission, and are excited to help drive this next phase of growth in enhancing the ability to deliver transformative care in a setting rooted in dignity, discretion, and clinical excellence.”
About Prospect Capital Corporation
Prospect is a business development company that primarily lends to and invests in middle market privately-held companies. Prospect’s investment objective is to generate both current income and long-term capital appreciation.
Prospect has elected to be treated as a business development company under the Investment Company Act of 1940. Prospect has elected to be treated as a regulated investment company under the Internal Revenue Code of 1986.
About Thesis Capital Partners
Based in Houston, Texas, Thesis Capital Partners is a sponsor investing in family-owned businesses across the United States. Thesis partners with exceptional entrepreneurs and management teams to guide and support operational transformation and business growth across a variety of industries.
Caution Concerning Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, whose safe harbor for forward-looking statements does not apply to business development companies. Any such statements, other than statements of historical fact, are highly likely to be affected by other unknowable future events and conditions, including elements of the future that are or are not under our control, and that we may or may not have considered; accordingly, such statements cannot be guarantees or assurances of any aspect of future performance. Actual developments and results are highly likely to vary materially from any forward-looking statements. Such statements speak only as of the time when made, and we undertake no obligation to update any such statement now or in the future.
For additional information, contact:
Grier Eliasek, President and Chief Operating Officer
Telephone (212) 448-0702
